Ensysce Biosciences, Inc.

Healthcare · Biotechnology · United States

Last price 0.421 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 8.19M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, designed to release clinically effective drugs only when exposed to specific physiological conditions; and Multi-Pill Abuse Resistance (MPAR) platform, an over-dose protection opioid prodrug technology. The company’s lead product candidate is PF614, a TAAP oxycodone prodrug candidate for the...